SFX by Ex Libris Inc.

Title:	HIV treatment failure: testing for HIV resistance in clinical practice
Source:	Science [0036-8075] Perrin, L yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Nowak, M A A. "Pre-existence and emergence of drug resistance in HIV-1 infection." Proceedings of the Royal Society B: Biological Sciences 264.1382 (1997): 631-7.
description	2.	Forbes, B A A. "Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus: evidence for conjugative exchange of resistance." Journal of bacteriology 153.2 (1983): 627-34.
description	3.	Black, D. "AIDS and HIV. The way forward?" British journal of addiction 85.3 (1990): 350-.
description	4.	Friedland, G H H. "Attaining higher goals in HIV treatment: the central importance of adherence." AIDS 13Suppl1.Sep: 61-72.
description	5.	Laurent, C. "Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults." Journal of acquired immune deficiency syndromes 38.1 (2004): 14-7.
description	6.	Gallant, J E E. "Strategies for long-term success in the treatment of HIV infection." JAMA 283.10: 1329-1334.
description	7.	Paintsil, E. "Resistance, resistance, go away: persistence of nevirapine-resistant HIV mutations in HIV-infected infants." AIDS 25.7 (2011): 997-9.
description	8.	Shet, A. "Designing a mobile phone-based intervention to promote adherence to antiretroviral therapy in South India." AIDS and Behavior 14.3 (2010): 716-720.
description	9.	d'Onofrio, A. "Periodically varying antiviral therapies: conditions for global stability of the virus free state." Applied mathematics and computation 168.2 (2005): 945-953.
description	10.	Roberts, Kathleen Johnston J. "Adherence communication: a qualitative analysis of physician-patient dialogue." AIDS 13.13 (1999): 1771-8.
description	11.	Joshi, H.R. R. "Optimal control of an HIV immunology model." Optimal control applications & methods 23.4 (2002): 199-213.
description	12.	Glezen, W P P. "Emerging infections: Pandemic influenza." Epidemiologic Reviews 18.1 (1996): 64-76.
description	13.	Ndoye, I. "Access to antiretroviral drugs and AIDS management in Senegal." AIDS 17.SUPPL. 3 (2003): 95-101.
description	14.	Malamba, D. "Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance." The lancet 360.9326 (2002): 34-40.
description	15.	H., W. Jaffe W. "Identity and Interspecific Transfer of Gentamicin-Resistance Plasmids in Staphylococcus aureus and Staphylococcus epidermidis." The Journal of infectious diseases 141.6 (1980): 738-747.
description	16.	Condra, Jon H. "Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor." Journal of virology 70.12 (1996): 8270-8276.
description	17.	Day, M. "HIV's subtle ways." New scientist 161.2168 (1999): 14-.
description	18.	Kitajima, T. "Access to antiretroviral therapy among HIV/AIDS patients in Khon Kaen Province, Thailand." AIDS care 17.3 (2005): 359-66.
description	19.	Dragsted, Ulrik Bak B. "Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study." The journal of infectious diseases 190.1 (2004): 148-55.
description	20.	Morisky, D E E. "Concurrent and predictive validity of a self-reported measure of medication adherence." Medical care 24.1: 67-74.